Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection

We report a case of retinopathy and uveitis associated with sofosbuvir therapy for hepatitis C infection. Case report. A 57-year-old-male developed ocular inflammation and retinopathy four weeks after the administration of sofosbuvir for a hepatitis C infection. Hearing loss, rheumatologic disease,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2016-05, Vol.8 (5), p.e597
Hauptverfasser: Chin-Loy, Katrina, Galaydh, Farah, Shaikh, Saad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page e597
container_title Curēus (Palo Alto, CA)
container_volume 8
creator Chin-Loy, Katrina
Galaydh, Farah
Shaikh, Saad
description We report a case of retinopathy and uveitis associated with sofosbuvir therapy for hepatitis C infection. Case report. A 57-year-old-male developed ocular inflammation and retinopathy four weeks after the administration of sofosbuvir for a hepatitis C infection. Hearing loss, rheumatologic disease, and essential tremor were also noted. The ophthalmic findings resolved with discontinuation of the drug.     The authors report a case of sofosbuvir induced retinopathy and uveitis, the first associated with this emerging therapy for hepatitis C. Ophthalmologists and other treating physicians should be aware of the ophthalmic side effects of this drug.
doi_str_mv 10.7759/cureus.597
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4895080</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1953436680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c262t-2c0e64ce491a27003d0c613ca4ef1d14be022fe9824cf179acc93df4c3ce152b3</originalsourceid><addsrcrecordid>eNpVkU9LAzEQxYMoKrUXP4AEvAmt-bebzUWQorYgCGpvQkizEzeim5pkK_32rq2KnmZg3vzmMQ-hY0rGUhbq3HYRujQulNxBh4yW1aiildj90x-gYUovhBBKJCOS7KMDJjkvJFGH6Okesm_D0uRmjU1b4_kKfPYJX6YUrDcZavzhc4Mfggtp0a18xI8NRLNcYxcinjQxtN7iKfSIzeIEz1oHNvvQHqE9Z14TDL_rAM2vrx4n09Ht3c1scnk7sqxkecQsgVJYEIoaJgnhNbEl5dYIcLSmYgGEMQeqYsI6KpWxVvHaCcst0IIt-ABdbLnLbvEGtYU2R_Oql9G_mbjWwXj9f9L6Rj-HlRaVKkhFesDpNyCG9w5S1i-hi23vWVNVcMHLcqM626psDClFcL8XKNFfYehtGLoPoxef_PX0K_15Pf8EO5CIdA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1953436680</pqid></control><display><type>article</type><title>Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Chin-Loy, Katrina ; Galaydh, Farah ; Shaikh, Saad</creator><creatorcontrib>Chin-Loy, Katrina ; Galaydh, Farah ; Shaikh, Saad</creatorcontrib><description>We report a case of retinopathy and uveitis associated with sofosbuvir therapy for hepatitis C infection. Case report. A 57-year-old-male developed ocular inflammation and retinopathy four weeks after the administration of sofosbuvir for a hepatitis C infection. Hearing loss, rheumatologic disease, and essential tremor were also noted. The ophthalmic findings resolved with discontinuation of the drug.     The authors report a case of sofosbuvir induced retinopathy and uveitis, the first associated with this emerging therapy for hepatitis C. Ophthalmologists and other treating physicians should be aware of the ophthalmic side effects of this drug.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.597</identifier><identifier>PMID: 27335709</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antiviral drugs ; Case reports ; Hepatitis C ; Ophthalmology</subject><ispartof>Curēus (Palo Alto, CA), 2016-05, Vol.8 (5), p.e597</ispartof><rights>Copyright © 2016, Chin-Loy et al. This work is licensed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2016, Chin-Loy et al. 2016 Chin-Loy et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895080/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895080/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27335709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chin-Loy, Katrina</creatorcontrib><creatorcontrib>Galaydh, Farah</creatorcontrib><creatorcontrib>Shaikh, Saad</creatorcontrib><title>Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>We report a case of retinopathy and uveitis associated with sofosbuvir therapy for hepatitis C infection. Case report. A 57-year-old-male developed ocular inflammation and retinopathy four weeks after the administration of sofosbuvir for a hepatitis C infection. Hearing loss, rheumatologic disease, and essential tremor were also noted. The ophthalmic findings resolved with discontinuation of the drug.     The authors report a case of sofosbuvir induced retinopathy and uveitis, the first associated with this emerging therapy for hepatitis C. Ophthalmologists and other treating physicians should be aware of the ophthalmic side effects of this drug.</description><subject>Antiviral drugs</subject><subject>Case reports</subject><subject>Hepatitis C</subject><subject>Ophthalmology</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpVkU9LAzEQxYMoKrUXP4AEvAmt-bebzUWQorYgCGpvQkizEzeim5pkK_32rq2KnmZg3vzmMQ-hY0rGUhbq3HYRujQulNxBh4yW1aiildj90x-gYUovhBBKJCOS7KMDJjkvJFGH6Okesm_D0uRmjU1b4_kKfPYJX6YUrDcZavzhc4Mfggtp0a18xI8NRLNcYxcinjQxtN7iKfSIzeIEz1oHNvvQHqE9Z14TDL_rAM2vrx4n09Ht3c1scnk7sqxkecQsgVJYEIoaJgnhNbEl5dYIcLSmYgGEMQeqYsI6KpWxVvHaCcst0IIt-ABdbLnLbvEGtYU2R_Oql9G_mbjWwXj9f9L6Rj-HlRaVKkhFesDpNyCG9w5S1i-hi23vWVNVcMHLcqM626psDClFcL8XKNFfYehtGLoPoxef_PX0K_15Pf8EO5CIdA</recordid><startdate>20160503</startdate><enddate>20160503</enddate><creator>Chin-Loy, Katrina</creator><creator>Galaydh, Farah</creator><creator>Shaikh, Saad</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20160503</creationdate><title>Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection</title><author>Chin-Loy, Katrina ; Galaydh, Farah ; Shaikh, Saad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c262t-2c0e64ce491a27003d0c613ca4ef1d14be022fe9824cf179acc93df4c3ce152b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antiviral drugs</topic><topic>Case reports</topic><topic>Hepatitis C</topic><topic>Ophthalmology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin-Loy, Katrina</creatorcontrib><creatorcontrib>Galaydh, Farah</creatorcontrib><creatorcontrib>Shaikh, Saad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin-Loy, Katrina</au><au>Galaydh, Farah</au><au>Shaikh, Saad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2016-05-03</date><risdate>2016</risdate><volume>8</volume><issue>5</issue><spage>e597</spage><pages>e597-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>We report a case of retinopathy and uveitis associated with sofosbuvir therapy for hepatitis C infection. Case report. A 57-year-old-male developed ocular inflammation and retinopathy four weeks after the administration of sofosbuvir for a hepatitis C infection. Hearing loss, rheumatologic disease, and essential tremor were also noted. The ophthalmic findings resolved with discontinuation of the drug.     The authors report a case of sofosbuvir induced retinopathy and uveitis, the first associated with this emerging therapy for hepatitis C. Ophthalmologists and other treating physicians should be aware of the ophthalmic side effects of this drug.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>27335709</pmid><doi>10.7759/cureus.597</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2016-05, Vol.8 (5), p.e597
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4895080
source PubMed Central Open Access; PubMed Central
subjects Antiviral drugs
Case reports
Hepatitis C
Ophthalmology
title Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retinopathy%20and%20Uveitis%20Associated%20with%20Sofosbuvir%20Therapy%20for%20Chronic%20Hepatitis%20C%20Infection&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Chin-Loy,%20Katrina&rft.date=2016-05-03&rft.volume=8&rft.issue=5&rft.spage=e597&rft.pages=e597-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.597&rft_dat=%3Cproquest_pubme%3E1953436680%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1953436680&rft_id=info:pmid/27335709&rfr_iscdi=true